Add like
Add dislike
Add to saved papers

Muscle-Specific Contributions to Vertical Ground Reaction Force Profiles During Countermovement Jumps: Case Studies in College Basketball Players.

Kipp, K and Kim, H. Muscle-specific contributions to vertical ground reaction force profiles during countermovement jumps: case studies in college basketball players. J Strength Cond Res XX(X): 000-000, 2022-The purpose of this study was to determine muscle-specific contributions to various types of vertical ground reaction force (vGRF) profiles in collegiate basketball players. Players from a men's ( n = 5; height: 1.84 ± 0.14 m; mass: 92.8 ± 11.4 kg) and a women's ( n = 5; 1.71 ± 0.09 m; mass: 80.1 ± 17.6 kg) basketball team completed 3-5 countermovement jumps (CMJ) while motion capture and force plate data were recorded. Muscle-specific contributions to vGRF were calculated through vGRF decomposition analysis. Profiles of vGRF were analyzed based on the presence of unimodal or bimodal peaks during the CMJ. The results showed that the soleus (SOL), gastrocnemii (GAS), vastii (VAS), and gluteus maximus (GMX) muscles all contributed to upward vGRF generation throughout the entire CMJ duration. The contributions were greatest for the SOL (1.78 body weight [BW]), intermediate for the GAS (0.96 BW) and VAS (0.72 BW), and negligible for the GMX (0.11 BW). For unimodal vGRF profiles, SOL contributions coincided with peak vGRF, whereas VAS contributions were stable throughout most of the CMJ. For bimodal vGRF profiles, SOL and VAS contributions explained the presence of the first vGRF peak, whereas GAS and VAS contributions explained the second vGRF peak. Differences between vGRF profiles appear to be the result of distinct force contributions from the VAS muscle, which may have implications for the analysis of vGRF time series data during CMJ testing.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app